Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CORVUS PHARMACEUTICALS, INC.

(CRVS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about CORVUS PHARMACEUTICALS, INC.
09/22Health Care Stocks Follow Market Higher Wednesday
MT
09/22Health Care Stocks Edge Higher Premarket Wednesday
MT
09/22CORVUS PHARMACEUTICALS : Reports Results of Phase 3 Trial of Mupadolimab; Shares Fall Pre-..
MT
09/22Corvus Pharmaceuticals Provides Updates on Mupadolimab (Anti-CD73) Programs in Oncology..
GL
09/22Corvus Pharmaceuticals Provides Updates on Mupadolimab
CI
09/17Top Premarket Gainers
MT
09/07Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences
GL
08/17CORVUS PHARMACEUTICALS : Announces IND Acceptance for Phase 1/1b Clinical Trial of CPI-1 i..
AQ
08/17CORVUS PHARMACEUTICALS' : Chinese Partner Gets Regulatory Nod to Conduct Early Stage Study..
MT
08/16CORVUS PHARMACEUTICALS' : Application for Phase 1 Clinical Trial Accepted by Chinese Regul..
MT
08/16CORVUS PHARMACEUTICALS : Announces IND Acceptance for Phase 1/1b Clinical Trial of CPI-818..
AQ
08/03CORVUS PHARMACEUTICALS : Provides Business Update and Reports Second Quarter 2021 Financia..
AQ
08/03CORVUS PHARMACEUTICALS : Cantor Fitzgerald Adjusts Price Target on Corvus Pharmaceuticals ..
MT
08/03CORVUS PHARMACEUTICALS : Mizuho Securities Adjusts Corvus Pharmaceuticals' Price Target to..
MT
08/03CORVUS PHARMACEUTICALS : Provides Business Update and Reports Second Quarter 2021 Financia..
PU
08/02CORVUS : Q2 Earnings Snapshot
AQ
08/02CORVUS PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and R..
AQ
08/02Corvus Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter Ended June..
CI
08/02CORVUS PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Financial St..
AQ
08/02CORVUS PHARMACEUTICALS : Earnings Flash (CRVS) CORVUS PHARMACEUTICALS Reports Q2 Loss $-0...
MT
08/02CORVUS PHARMACEUTICALS : Provides Business Update and Reports Second Quarter 2021áFinancia..
AQ
07/16CORVUS PHARMACEUTICALS : HC Wainwright Adjusts Corvus Pharmaceuticals' Price Target to $6 ..
MT
07/16SECTOR UPDATE : Health Care Stocks Eke Out Small Gains In Premarket Friday
MT
07/16UPDATE : Corvus Pharma Discontinues Phase 3 COVID-19 Study as Serious Infections, Hospital..
MT
07/16NORTH AMERICAN MORNING BRIEFING : Retail Sales Awaited; Intel in Focus Amid M&A
DJ
07/15CORVUS PHARMACEUTICALS : Discontinues Phase 3 COVID-19 Study as Serious Infections, Hospit..
MT
07/15CORVUS PHARMACEUTICALS : Discontinues Phase 3 Study of Mupadolimab (Anti-CD73) for COVID-1..
PU
07/15CORVUS PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Other Events..
AQ
07/15Corvus Pharmaceuticals, Inc. Discontinues Phase 3 Study of Mupadolimab (Anti-CD73) for ..
CI
07/15CORVUS PHARMACEUTICALS : Discontinues Phase 3 Study of Mupadolimab (Anti-CD73) for COVID-1..
AQ
06/25CORVUS PHARMACEUTICALS, INC.(NASDAQG : CRVS) dropped from Russell 3000E Growth Index
CI
06/25CORVUS PHARMACEUTICALS, INC.(NASDAQG : CRVS) dropped from Russell Microcap Growth Index
CI
06/25CORVUS PHARMACEUTICALS, INC.(NASDAQG : CRVS) added to Russell 3000E Value Index
CI
06/25CORVUS PHARMACEUTICALS, INC.(NASDAQG : CRVS) added to Russell Microcap Value Index
CI
06/16CORVUS PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8..
AQ
05/27CORVUS PHARMACEUTICALS : Cantor Fitzgerald Starts Corvus Pharmaceuticals With Overweight R..
MT
05/25Corvus Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
GL
05/14Certain Options of Corvus Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Endi..
CI
05/14Certain Common Stock of Corvus Pharmaceuticals, Inc. are subject to a Lock-Up Agreement..
CI
05/14Certain Warrants of Corvus Pharmaceuticals, Inc. are subject to a Lock-Up Agreement End..
CI
05/05Corvus Pharmaceuticals Completes Sale of $10 Million Through Its ATM Program
GL
04/30CORVUS PHARMACEUTICALS : Provides Business Update and Reports First Quarter 2021 Financial..
AQ
04/29CORVUS : Q1 Earnings Snapshot
AQ
04/29Corvus Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March..
CI
03/26CORVUS PHARMACEUTICALS : HC Wainwright Adjusts Price Target on Corvus Pharmaceuticals to $..
MT
03/25CORVUS PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and R..
AQ
03/25Corvus Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December ..
CI
03/25CORVUS : Q4 Earnings Snapshot
AQ
03/25CORVUS PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Financial St..
AQ
03/25CORVUS PHARMACEUTICALS : Provides Business Update and Reports Fourth Quarter and Full Year..
AQ
03/25CORVUS PHARMACEUTICALS : Earnings Flash (CRVS) CORVUS PHARMACEUTICALS Reports Q4 EPS $0.92
MT
03/22Corvus Pharmaceuticals, Inc. Announces Not to Stand for the Re-Election of Steve Krogne..
CI
03/22CORVUS PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
03/05Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences
GL
02/22CORVUS PHARMACEUTICALS : CRVS) Insiders Make Significant Share purchases Continuing the Tr..
MT
02/19INSIDER TRENDS : Corvus Pharmaceuticals Insider 90-Day Buying Trend Added to with Purchase
MT
02/19INSIDER TRENDS : Corvus Pharmaceuticals Insider Buy Scaling Back 90-Days of Sells
MT
02/17INSIDER TRENDS : 90-Day Insider Selling Trend at Corvus Pharmaceuticals Eased Back with Ac..
MT
02/17CORVUS PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
02/17Corvus Pharmaceuticals Announces Closing of Public Offering of Common Stock
GL
02/15CORVUS PHARMACEUTICALS : Announces Pricing of Public Offering of Common Stock
AQ
02/12CORVUS PHARMACEUTICALS : Prices Common Share Offering at $3.50 Apiece; Shares Drop
MT
02/12Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
GL
02/11CORVUS PHARMACEUTICALS, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
02/11CORVUS PHARMACEUTICALS : Kicks Off Common Stock Offering; Shares Down 8% After Hours
MT
02/11Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock
GL
02/10CORVUS PHARMACEUTICALS : Mizuho Downgrades Corvus Pharmaceuticals to Neutral From Buy, Adj..
MT
02/04CORVUS PHARMACEUTICALS : Launches Phase 3 Clinical Trial of COVID-19 Treatment Candidate C..
MT
02/04CORVUS PHARMACEUTICALS, INC. : Other Events (form 8-K)
AQ
02/04Corvus Pharmaceuticals Initiates Phase 3 Clinical Trial of CPI-006 for Patients with CO..
GL
02/04Corvus Pharmaceuticals Initiates Phase 3 Clinical Trial of CPI-006 for Patients with CO..
CI
2020CORVUS PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2020CORVUS PHARMACEUTICALS : Presents New Data on its Investigational ITK Inhibitor CPI-818 at..
AQ
2020CORVUS PHARMACEUTICALS, INC. : Other Events (form 8-K)
AQ
2020Corvus Presents New Data on its Investigational ITK Inhibitor CPI-818 at the American S..
GL
1  2  3  4Next
Upcoming event on CORVUS PHARMACEUTICALS, INC.
11/04/21